Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Hisamitsu Pharmaceutical Co ( (JP:4530) ) has provided an update.
Hisamitsu Pharmaceutical Co., Inc. announced the appointment of 10 directors, including two new appointments, at its 123rd annual general meeting. This strategic move is expected to strengthen the company’s leadership and enhance its operational capabilities, potentially impacting its market position and stakeholder relations positively.
More about Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Inc. operates in the pharmaceutical industry, focusing on the development and production of medical products. The company is known for its transdermal therapeutic systems and other pharmaceutical products, serving a global market with innovative healthcare solutions.
Average Trading Volume: 173,336
Technical Sentiment Signal: Buy
Current Market Cap: Yen332.3B
Learn more about 4530 stock on TipRanks’ Stock Analysis page.